21st Annual Mount Sinai Inflammatory Bowel Disease Consultants Course: State of the Art Management

Friday, April 17, 2026, 7:00 AM - 4:00 PM, 1470 Madison Avenue, 2nd Floor, Davis Auditorium, New York, NY


The Mount Sinai 2026 Inflammatory Bowel Disease Consultant’s Course is a one-day, in-person educational program focused on practical, evidence-based management of inflammatory bowel disease (IBD). Designed for gastroenterologists caring for patients in community and referral settings, the course emphasizes real-world clinical decision-making across the full spectrum of IBD care. Expert faculty from the Mount Sinai IBD Center will translate advances in biologics, small molecules, monitoring strategies, and multidisciplinary management into actionable approaches for daily practice. The program features concise didactic sessions, interactive case workshops, and audience-driven discussions addressing treatment selection and sequencing, refractory disease, dysplasia surveillance, cancer risk, pregnancy, acute severe ulcerative colitis, and long-term disease monitoring.

1. Apply practical, evidence-based strategies to select, sequence, and optimize therapies for Crohn’s disease and ulcerative colitis.
2. Integrate monitoring tools—including biomarkers, therapeutic drug monitoring, and imaging—into feasible treat-to-target approaches.
3. Manage complex and high-risk IBD scenarios, including refractory disease, dysplasia and cancer risk, pregnancy, and acute severe ulcerative colitis.

Registration is complimentary and must be completed online. 

Cancellation Policy
All refund and cancellation requests must be emailed to the CME office at [email protected] by April 3, 2026. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal to or less than $50.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. Relevant financial relationships are mitigated and disclosed to learners before the activity takes place. All relevant financial relationships have been mitigated.